Lipella Pharmaceuticals Inc.
February 11, 2025
Plymouth
Orphan/Rare Diseases
Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing innovative treatments for serious diseases. Our proprietary drug delivery technology offers potential solutions for conditions affecting mucosal tissues, including those in the oral cavity and bladder. We believe our technology has strong potential for strategic partnerships and commercial licensing agreements to accelerate development and bring transformative treatments to market.
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}